Uygunsuz İmplante Edilebilir Kardiyoverter Defibrilatör (ICD) Şokları ve Yönetimi
Özet
Referanslar
Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ; MADIT II Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008 Apr 8;51(14):1357-65. doi: 10.1016/j.jacc.2007.09.073. PMID: 18387436.
Kreuz J, Balta O, Liliegren N, Mellert F, Esmailzadeh B, Nickenig G, Schwab JO. Incidence and characteristics of appropriate and inappropriate therapies in recipients of ICD implanted for primary prevention of sudden cardiac death. Pacing Clin Electrophysiol. 2007 Jan;30 Suppl 1:S125-7. doi: 10.1111/j.1540-8159.2007.00621.x. Erratum in: Pacing Clin Electrophysiol. 2007 Nov;30(11):1427. PMID: 17302687.
Frieder Braunschweig, Giuseppe Boriani, Alexander Bauer, Robert Hatala, Christoph Herrmann-Lingen, Josef Kautzner, Susanne S. Pedersen, Steen Pehrson, Renato Ricci, Martin J. Schalij, Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management, EP Europace, Volume 12, Issue 12, December 2010, Pages 1673–1690
Braunschweig F, Boriani G, Bauer A, et al.Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management. Europace 2010;12:1673–90.
StevensonWG, Chaitman BR, Ellenbogen KA, et al. Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists. Circulation 2004;110:3866–9.
Clemo HF, Ellenbogen KA. My defibrillator fired: what to do? Am Coll Cardiol Curr J Rev 2001;10:76–81.
Auricchio A, Schloss EJ, Kurita T, et al. Lowinappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results. Heart Rhythm 2015;12:926–36.
Connolly SJ, Dorian P, Roberts RS, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks fromimplantable cardioverter defibrillators: the OPTIC study, a randomized trial. JAMA 2006;295:165–71
Atwater BD, Daubert JP. Implantable cardioverter defibrillators: risks accompany the life-saving benefits. Heart 2012;98:764–72.
Mishkin JD, Saxonhouse SJ,Woo GW, et al. Appropriate evaluation and treatment of heart failure patients after implantable cardiac defibrillator discharge: time to go beyond the initial shock. J Am Coll Cardiol 2009;54:1993–2000.
Wilkoff BL, Love CJ, Byrd CL, et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management. Heart Rhythm 2009;6:1085–104.
Referanslar
Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ; MADIT II Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008 Apr 8;51(14):1357-65. doi: 10.1016/j.jacc.2007.09.073. PMID: 18387436.
Kreuz J, Balta O, Liliegren N, Mellert F, Esmailzadeh B, Nickenig G, Schwab JO. Incidence and characteristics of appropriate and inappropriate therapies in recipients of ICD implanted for primary prevention of sudden cardiac death. Pacing Clin Electrophysiol. 2007 Jan;30 Suppl 1:S125-7. doi: 10.1111/j.1540-8159.2007.00621.x. Erratum in: Pacing Clin Electrophysiol. 2007 Nov;30(11):1427. PMID: 17302687.
Frieder Braunschweig, Giuseppe Boriani, Alexander Bauer, Robert Hatala, Christoph Herrmann-Lingen, Josef Kautzner, Susanne S. Pedersen, Steen Pehrson, Renato Ricci, Martin J. Schalij, Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management, EP Europace, Volume 12, Issue 12, December 2010, Pages 1673–1690
Braunschweig F, Boriani G, Bauer A, et al.Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management. Europace 2010;12:1673–90.
StevensonWG, Chaitman BR, Ellenbogen KA, et al. Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists. Circulation 2004;110:3866–9.
Clemo HF, Ellenbogen KA. My defibrillator fired: what to do? Am Coll Cardiol Curr J Rev 2001;10:76–81.
Auricchio A, Schloss EJ, Kurita T, et al. Lowinappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results. Heart Rhythm 2015;12:926–36.
Connolly SJ, Dorian P, Roberts RS, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks fromimplantable cardioverter defibrillators: the OPTIC study, a randomized trial. JAMA 2006;295:165–71
Atwater BD, Daubert JP. Implantable cardioverter defibrillators: risks accompany the life-saving benefits. Heart 2012;98:764–72.
Mishkin JD, Saxonhouse SJ,Woo GW, et al. Appropriate evaluation and treatment of heart failure patients after implantable cardiac defibrillator discharge: time to go beyond the initial shock. J Am Coll Cardiol 2009;54:1993–2000.
Wilkoff BL, Love CJ, Byrd CL, et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management. Heart Rhythm 2009;6:1085–104.
